ConductScience.org, home

Paper34273003

Resveratrol effects in oral cancer cells: a comprehensive review.

Almeida TC and 6 others. Med Oncol, 2021. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Resveratrol effects in oral cancer cells: a comprehensive review. Papers, record 34273003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34273003

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Resveratrol effects in oral cancer cells: a comprehensive review.
PubMed
Journal
Med Oncol
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
1.32
iCite
Revised in PubMed
2026-10-10
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Almeida TCTamires Cunha
2da Silva GNGlenda Nicioli
3de Souza DVDaniel Vitor
4de Moraes Malinverni ACAndrea Cristina
5Aguiar O JrOdair
6Estadella DDebora
7Ribeiro DADaniel Arakihttps://orcid.org/0000-0001-5057-4983

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Agents, PhytogenicMajor topic
AntioxidantsMajor topic
Mouth NeoplasmsMajor topic
ResveratrolMajor topic
Cell Survival
Humans
Oxidative Stress

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
001cnpqPubMed
001cnpqPubMed
001capesPubMed
001capesPubMed

Source PubMed

Download CSV of grants

References60

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133747905Resveratrol Mediates the Apoptosis of Triple Negative Breast Cancer Cells by Reducing POLD1 Expression.Front Oncol2021https://conductscience.org/library/papers/33747905PubMed
227583211Distant metastasis from oral cancer: A review and molecular biologic aspects.J Int Soc Prev Community Dent2016https://conductscience.org/library/papers/27583211PubMed
331883986NDAT suppresses pro-inflammatory gene expression to enhance resveratrol-induced anti-proliferation in oral cancer cells.Food Chem Toxicol2020https://conductscience.org/library/papers/31883986PubMed
432423320Combination of Resveratrol and Quercetin Causes Cell Growth Inhibition, DNA Damage, Cell Cycle Arrest, and Apoptosis in Oral Cancer Cells.Assay Drug Dev Technol2020https://conductscience.org/library/papers/32423320PubMed
526776043Determination of phenolic compounds content and antioxidant activity in skin, pulp, seed, cane and leaf of five native grape cultivars in West Azerbaijan province, Iran.Food Chem2016https://conductscience.org/library/papers/26776043PubMed
627742160Chemotherapeutic effects of luteolin on radio-sensitivity enhancement and interleukin-6/signal transducer and activator of transcription 3 signaling repression of oral cancer stem cells.J Formos Med Assoc2016https://conductscience.org/library/papers/27742160PubMed
732728068Zeb1 for RCP-induced oral cancer cell invasion and its suppression by resveratrol.Exp Mol Med2020https://conductscience.org/library/papers/32728068PubMed
833686517Predictive Value of EGFR-PI3K-AKT-mTOR-Pathway Inhibitor Biomarkers for Head and Neck Squamous Cell Carcinoma: A Systematic Review.Mol Diagn Ther2021https://conductscience.org/library/papers/33686517PubMed
926409447Resveratrol inhibits oral squamous cell carcinoma through induction of apoptosis and G2/M phase cell cycle arrest.Tumour Biol2016https://conductscience.org/library/papers/26409447PubMed
1033655717Resveratrol-loaded nanomedicines for cancer applications.Cancer Rep (Hoboken)2021https://conductscience.org/library/papers/33655717PubMed
1133535458The Effects of Resveratrol on Prostate Cancer through Targeting the Tumor Microenvironment.J Xenobiot2021https://conductscience.org/library/papers/33535458PubMed
1233406721Impact of Environmental Factors on Stilbene Biosynthesis.Plants (Basel)2021https://conductscience.org/library/papers/33406721PubMed
1329381815Effects of polyphenols on doxorubicin-induced oral keratinocyte cytotoxicity and anticancer potency against oral cancer cells.J Oral Pathol Med2018https://conductscience.org/library/papers/29381815PubMed
1424243690Grape seed extract and resveratrol prevent 4-nitroquinoline 1-oxide induced oral tumorigenesis in mice by modulating AMPK activation and associated biological responses.Mol Carcinog2015https://conductscience.org/library/papers/24243690PubMed
1519761189Phytochemical profiles of different mulberry (Morus sp.) species from China.J Agric Food Chem2009https://conductscience.org/library/papers/19761189PubMed
1621680702Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics.Cancer Prev Res (Phila)2011https://conductscience.org/library/papers/21680702PubMed
1724384874Effects of resveratrol on oral squamous cell carcinoma (OSCC) cells in vitro.J Cancer Res Clin Oncol2014https://conductscience.org/library/papers/24384874PubMed
1830554657Increased expression of tripartite motif (TRIM) like 2 promotes tumoral growth in human oral cancer.Biochem Biophys Res Commun2019https://conductscience.org/library/papers/30554657PubMed
1923385513Oral cancer: Current role of radiotherapy and chemotherapy.Med Oral Patol Oral Cir Bucal2013https://conductscience.org/library/papers/23385513PubMed
2029148840Resveratrol Induces Mitochondrial Apoptosis and Inhibits Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Cells.Nutr Cancer2018https://conductscience.org/library/papers/29148840PubMed

See all 60 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
41226384Roles of Selected Bioactive Compounds in Inhibiting the Development and Progression of Cancer-A Review.Int J Mol Sci2025https://conductscience.org/library/papers/41226384PubMed
40888184Resveratrol: Sensitising CD44+ Cervical Cancer Cells to Carboplatin and Mitigating Metastasis.Cancer Med2025https://conductscience.org/library/papers/40888184PubMed
40653555Resveratrol in oral cancer: a systematic review of preclinical studies on its anticancer mechanisms and therapeutic potential.Med Oncol2025https://conductscience.org/library/papers/40653555PubMed
39062744Identification and Comprehensive Analysis of circRNA-miRNA-mRNA Regulatory Networks in A2780 Cells Treated with Resveratrol.Genes (Basel)2024https://conductscience.org/library/papers/39062744PubMed
38575921A systematic review and meta-analysis of the impact of resveratrol on oral cancer: potential therapeutic implications.BMC Oral Health2024https://conductscience.org/library/papers/38575921PubMed
37859687Exploring the potential of dietary factors and plant extracts as chemopreventive agents in oral squamous cell carcinoma treatment.Front Oral Health2023https://conductscience.org/library/papers/37859687PubMed
36829966Melanoma Cellular Signaling Transduction Pathways Targeted by Polyphenols Action Mechanisms.Antioxidants (Basel)2023https://conductscience.org/library/papers/36829966PubMed
35387267Research Progress on Natural Products' Therapeutic Effects on Atrial Fibrillation by Regulating Ion Channels.Cardiovasc Ther2022https://conductscience.org/library/papers/35387267PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34273003

GET https://conductscience.org/api/papers/v1/34273003/references?page=2